Kasparas Zilinskas

Kasparas Zilinskas

Auto-generated profile, based on publicly available information

Kasparas Zilinskas

Medical University of South Carolina, Charleston, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TRT. Konrad Rajab
T. Konrad Rajab
BOBrielle Ochoa
Brielle Ochoa
KZKasparas Zilinskas
Kasparas Zilinskas
JKJennie Kwon
Jennie Kwon
CTCarolyn L Taylor
Carolyn L Taylor
JCJohn M Costello
John M Costello
Congenital heart defects are the most common type of birth defects in humans and frequently involve heart valve dysfunction. The current treatment for unrepairable heart valves involves valve replacement with an implant, Ross pulmonary autotransplantation, or conventional orthotopic heart transplantation. Although these treatments are appropriate for older children and adults, they do not result in the same efficacy and durability in infants and young children for several reasons. Heart valve implants do not grow with the. Ross pulmonary autotransplants have a high mortality rate in neonates and are not feasible if the pulmonary valve is dysfunctional or absent. Furthermore, orthotopic heart transplants invariably fail from ventricular dysfunction over time. Therefore, the treatment of irreparable heart valves in infants and young children remains an unsolved problem. The objective of this single-arm, prospective study is to offer an alternative solution based on a new type of transplant, which we call “partial heart transplantation.” Partial heart transplantation differs from conventional orthotopic heart transplantation because only the part of the heart containing the heart valve is transplanted. Similar to Ross pulmonary autotransplants and conventional orthotopic heart transplants, partial heart transplants contain live cells that should allow it to grow with the recipient child. Therefore, partial heart transplants will require immunosuppression. The risks from immunosuppression can be managed, as seen in conventional orthotopic heart transplant recipients. Stopping immunosuppression will simply turn the growing partial heart transplant into a non-growing homovital homograft. Once this homograft deteriorates, it can be replaced with a durable adult-sized mechanical implant. The protocol for our single-arm trial is described. The ClinicalTrials.gov trial registration number is NCT05372757.

1 August 2024 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
PDF file
KZKasparas Zilinskas
Kasparas Zilinskas
RMRohit Mittal
Rohit Mittal
KHKathleen Hollowed
Kathleen Hollowed
SKSteven A Kahn
Steven A Kahn
CO2 ablative fractional laser (CO2 AFL) therapy is a safe and effective procedure when used in the treatment of hypertrophic scars for burn patients. It has a high patient satisfaction rate and a minimal side effect profile, typically consisting of postoperative pain, irritation, surgical site inflammation, and, in rare cases, infection. Although prophylactic antibiotics have historically been recommended, there is a paucity of literature on the topic and recent studies indicate that they may be unnecessary in routine cases. In this retrospective, single center descriptive study, 230 cases in patients with hypertrophic burn scars treated with CO2 AFL therapy were compared. 28 cases were with the use of prophylactic antibiotics and 201 cases were without the use of prophylactic antibiotics. We found that there was no significant association between the use of antibiotics and the prevention of topical skin infection in cases treated with CO2 AFL therapy (p=1). Therefore, we conclude that the omission of prophylactic antibiotics is not associated with an increased risk of infection and recommend that prophylactic antibiotics should not be indicated in the setting of routine CO2 AFL therapy for patients with hypertrophic burn scars.

16 September 2025 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
JTJenna Thuman
Jenna Thuman
KZKasparas Zilinskas
Kasparas Zilinskas
AHAlexander Hoey
Alexander Hoey
RBRebecca Brantley
Rebecca Brantley
ISIsis Scomacao
Isis Scomacao
NPNiyant Patel
Niyant Patel
Standardized technique and outcome of surgical reduction of macroglossia have yet to be determined. The aim of our study is to review current literature regarding the clinical and surgical management of primary macroglossia and postoperative outcomes in the pediatric population. A systematic review was performed between the years of 1995 and 2024 according to PRISMA guidelines. Search terms included “glossectomy,” “children,” and “macroglossia.” Studies were analyzed for level of evidence, sample and control sizes, indications for surgery, surgical reduction technique, complications, follow-up length, and pre- and postoperative assessments of speech, feeding, orthodontics, oral incompetence, and airway obstruction. Of 1566 studies, 74 were selected for final use. Indications for surgery were airway obstruction (37.8%), oral incompetence (27%), orthodontic changes (46%), feeding/speech difficulties (39.2% and 41.9%, respectively), or cosmesis (14.9%). The most common surgical techniques used included keyhole (23.3%), followed by anterior tip (14.9%), central wedge (6.8%), and modified keyhole (6.8%). Surgical technique was not included in 22 studies (29.7%). Postoperative assessments were not included in 27 (36.5%); of those that did include, reported improvements included speech (29.7%), feeding (24.3%), orthognathic/orthodontic (12.1%), airway obstruction (17.6%), and oral incompetence (13.5%) with surgery alone. Complications, when reported, included dehiscence (13.5%), infection (1.35%), and recurrence (17.6%). This is the largest systematic review to date on macroglossia reduction. Prior studies lack characteristics of quality studies, inconsistently report treatment variables/outcomes, have poor levels of evidence, and lack long-term follow-up. No consensus on diagnosis, treatment, timing of surgery, surgical technique, or adjuvant treatments for macroglossia exist.

4 March 2026 in HAND
Verified
Journal Article
Closed access
KZKasparas Zilinskas
Kasparas Zilinskas
RBReena Bakshi
Reena Bakshi
KCKristin Clemmons
Kristin Clemmons
MZMelanie Bertolino Zilinskas
Melanie Bertolino Zilinskas
AHAlexander Hoey
Alexander Hoey
MTManoucher Lance Tavana
Manoucher Lance Tavana
Background: Carpal tunnel release (CTR) is commonly performed using wide-awake local anesthesia no tourniquet (WALANT) in a clinic or ambulatory surgery center and is shown to have similar satisfaction rates and postoperative complication profile compared to operating room (OR) procedures. Endoscopic carpal tunnel release (ECTR) is commonly performed; however, it is usually done in an OR setting with the use of anesthesia (OR-ECTR). We present a single institution’s experience performing ECTR utilizing a tourniquet under local only anesthesia (LO-ECTR). We compared procedural efficiency and environmental impact between OR-ECTR and LO-ECTR. In addition, patient satisfaction with LO-ECTR was assessed via a postprocedural survey. Methods: A retrospective review identified patients who underwent OR-ECTR and LO-ECTR from June 2021 to June 2023 by a single surgeon at our institution. Efficiency was measured by comparing procedure, recovery, and total time spent in the hospital. Environmental impact was assessed by measuring OR waste weight. Student’s t -tests for continuous variables and Chi-squared tests for categorical variables were performed. Patients in the LO-ECTR group answered a survey immediately postoperatively that included pain scores on a Likert scale and overall satisfaction. Inclusion criteria included primary carpal tunnel syndrome (CTS), diagnosis based on clinical or electromyography studies, and no concurrent procedures. The Microaire SmartRelease ECTR system was used in the OR-ECTR cases, and the Trice Seg-WAY ECTR-d system was used in the LO-ECTR cases. Results: A total of 137 cases in the LO-ECTR and 104 cases in the OR-ECTR group met inclusion criteria. Age, body mass index, operative hand, and race were similar between both groups. LO-ECTR procedures were faster than OR-ECTR procedures for all time metrics. Total procedure and operating time improved (9 ± 2 minutes vs 14 ± 4 minutes and 15 ± 2 minutes vs 28 ± 6 minutes). Preoperative holding time improved (35 ± 15 minutes vs 89 ± 30 minutes). Recovery time was notably faster (7 ± 4 minutes vs 48 ± 22 minutes), which affected total hospital time (61.9 ± 18.6 minutes vs 166.9 ± 38.3 minutes). All differences were statistically significant with P < .001. Waste weights were significantly lower in the LO-ECTR cohort than those in the OR-ECTR cohort; however, sample sizes were small in both cohorts (1.3 ± 0.04 kg in LO-ECTR vs 6.0 ± 0.7 kg in OR-ECTR, P < .001). Within the LO-ECTR group, the overall pain level experience was mild/moderate. The average overall satisfaction with the experience was 96.6%, with 98.5% of patients stating they would recommend this procedure to a friend. Conclusion: LO-ECTR was faster than OR-ECTR for all studied time metrics. Data are suggestive of improvement in the environmental impact factor. Limitations include a lack of meaningful postoperative patient events and retrospective nature of the study. Further studies will investigate long-term outcomes in the LO-ECTR group.